-
1
-
-
0034463114
-
Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2
-
Blutt SE, McDonnell TJ, Polek TC, Weigel NL. 2000. Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology 141:10-17.
-
(2000)
Endocrinology
, vol.141
, pp. 10-17
-
-
Blutt, S.E.1
McDonnell, T.J.2
Polek, T.C.3
Weigel, N.L.4
-
2
-
-
0000595375
-
Vitamin D and prostate cancer
-
Feldman D, Glorieux FH, Pike WP, editors. San Diego: Academic Press
-
Gross C, Peehl DM, Feldman D. 1997. Vitamin D and prostate cancer. In: Feldman D, Glorieux FH, Pike WP, editors. Vitamin D. San Diego: Academic Press, pp 1125-1200.
-
(1997)
Vitamin D
, pp. 1125-1200
-
-
Gross, C.1
Peehl, D.M.2
Feldman, D.3
-
3
-
-
0345450445
-
A group of deltanoids (vitamin D analogs) regulate cell growth and proliferation in small cell carcinoma cell lines
-
Guzey M, DeLuca HF. 1997. A group of deltanoids (vitamin D analogs) regulate cell growth and proliferation in small cell carcinoma cell lines. Res Commun Mol Pathol Pharmacol 98:3-18.
-
(1997)
Res Commun Mol Pathol Pharmacol
, vol.98
, pp. 3-18
-
-
Guzey, M.1
DeLuca, H.F.2
-
5
-
-
0003448569
-
Immunoblotting
-
New York: Cold Spring Harbor Laboratories, INC.
-
Harlow E, Lane D. 1999. Immunoblotting. In: Using antibodies. New York: Cold Spring Harbor Laboratories, INC. 267-309.
-
(1999)
Using Antibodies
, pp. 267-309
-
-
Harlow, E.1
Lane, D.2
-
6
-
-
0031892913
-
The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed
-
Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW. 1998. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349.
-
(1998)
J Bone Miner Res
, vol.13
, pp. 325-349
-
-
Haussler, M.R.1
Whitfield, G.K.2
Haussler, C.A.3
Hsieh, J.C.4
Thompson, P.D.5
Selznick, S.H.6
Dominguez, C.E.7
Jurutka, P.W.8
-
7
-
-
0034991936
-
Vitamin D receptor null mutant mice fed high levels of calcium are fertile
-
Johnson LE, DeLuca HF. 2001. Vitamin D receptor null mutant mice fed high levels of calcium are fertile. J Nutr 131:1787-1791.
-
(2001)
J Nutr
, vol.131
, pp. 1787-1791
-
-
Johnson, L.E.1
DeLuca, H.F.2
-
8
-
-
0031755168
-
Current understanding of the molecular actions of vitamin D
-
Jones G, Strugnell SA, DeLuca HF. 1998. Current understanding of the molecular actions of vitamin D. Physiol Rev 78:1193-1231.
-
(1998)
Physiol Rev
, vol.78
, pp. 1193-1231
-
-
Jones, G.1
Strugnell, S.A.2
Deluca, H.F.3
-
9
-
-
0033836361
-
BMP-2 induces the expression of activin betaA and follistatin in vitro
-
Kearns AE, Demay MB. 2000. BMP-2 induces the expression of activin betaA and follistatin in vitro. J Cell Biochem 79:80-88.
-
(2000)
J Cell Biochem
, vol.79
, pp. 80-88
-
-
Kearns, A.E.1
Demay, M.B.2
-
10
-
-
0030610422
-
Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia
-
Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB. 1997. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:9831-9835.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 9831-9835
-
-
Li, Y.C.1
Pirro, A.E.2
Amling, M.3
Delling, G.4
Baron, R.5
Bronson, R.6
Demay, M.B.7
-
11
-
-
0033324493
-
Liarozole acts synergistically with 1alpha, 25-dihydroxyvitamin D3 to inhibit growth of DU-145 human prostate cancer cells by blocking 24-hydroxylase activity
-
Ly LH, Zhao XY, Holloway L, Feldman D. 1999. Liarozole acts synergistically with 1alpha, 25-dihydroxyvitamin D3 to inhibit growth of DU-145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology 140:2071-2079.
-
(1999)
Endocrinology
, vol.140
, pp. 2071-2079
-
-
Ly, L.H.1
Zhao, X.Y.2
Holloway, L.3
Feldman, D.4
-
12
-
-
0026601581
-
The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha, 25-dihydroxyvitamin D3
-
Miller GJ, Stapleton GE, Ferrara JA, Lucia MS, Pfister S, Hedlund TE, Upadhya P. 1992. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha, 25-dihydroxyvitamin D3. Cancer Res 52:515-520.
-
(1992)
Cancer Res
, vol.52
, pp. 515-520
-
-
Miller, G.J.1
Stapleton, G.E.2
Ferrara, J.A.3
Lucia, M.S.4
Pfister, S.5
Hedlund, T.E.6
Upadhya, P.7
-
14
-
-
0034791264
-
Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts
-
Thompson PD, Remus LS, Hsieh JC, Jurutka PW, Whitfield GK, Galligan MA, Encinas DC, Haussier CA, Haussler MR. 2001. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts. J Mol Endocrinol 27:211-227.
-
(2001)
J Mol Endocrinol
, vol.27
, pp. 211-227
-
-
Thompson, P.D.1
Remus, L.S.2
Hsieh, J.C.3
Jurutka, P.W.4
Whitfield, G.K.5
Galligan, M.A.6
Encinas, D.C.7
Haussier, C.A.8
Haussler, M.R.9
-
15
-
-
0002380415
-
Anticancer and differentiation
-
Feldman D, Glorieuex FH, Pike JW, editors. San Diego, CA: Academic Press
-
van Leeuwen JPTM, Pols HAP. 1997. Anticancer and differentiation. In: Feldman D, Glorieuex FH, Pike JW, editors. Vitamin D. San Diego, CA: Academic Press, pp 1089-1105.
-
(1997)
Vitamin D
, pp. 1089-1105
-
-
Van Leeuwen, J.P.T.M.1
Pols, H.A.P.2
-
16
-
-
0037662294
-
Vitamin D-3 receptor as a target for breast cancer prevention
-
Welsh J, Wietzke JA, Zinser GM, Byrne B, Smith K, Narvaez CJ. 2003. Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr 133:24258-24333.
-
(2003)
J Nutr
, vol.133
, pp. 24258-24333
-
-
Welsh, J.1
Wietzke, J.A.2
Zinser, G.M.3
Byrne, B.4
Smith, K.5
Narvaez, C.J.6
-
18
-
-
0036333333
-
Vitamin D(3) receptor ablation alters mammary gland morphogenesis
-
Zinser G, Packman K, Welsh J. 2002. Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development 129:3067-3076.
-
(2002)
Development
, vol.129
, pp. 3067-3076
-
-
Zinser, G.1
Packman, K.2
Welsh, J.3
|